Giant cell arteritis: Disease patterns of clinical presentation in a series of 240 patients

Medicine

Volumn 84, Issue 5, 2005, Pages 269-276

  Gonzalez Gay, Miguel A ^a   Barros, Sonia ^a   Lopez Diaz, Maria J ^a   Garcia Porrua, Carlos ^a   Sanchez Andrade, Amalia ^a   Llorca, Javier ^b  

^a HOSPITAL XERAL CALDE   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANEMIA; CLINICAL FEATURE; FEMALE; GIANT CELL ARTERITIS; HEADACHE; HUMAN; HUMAN TISSUE; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREDICTION; PRIORITY JOURNAL; REVIEW; RHEUMATIC POLYMYALGIA; RISK; SPAIN; SUBCLINICAL DISEASE; SYMPTOMATOLOGY; TEMPORAL ARTERY;

AGE FACTORS; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEADACHE; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; POLYMYALGIA RHEUMATICA; RETROSPECTIVE STUDIES; SPAIN; TEMPORAL ARTERITIS;

EID: 25444476131     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.md.0000180042.42156.d1     Document Type: Review

References (45)

1. Aiello PD, Trautmann JC, McPhee TJ, Kunselman AR, Hunder GG. Visual prognosis in giant cell arteritis. Ophthalmology. 1993;100:550-555.
2. Calamia KT, Hunder GG. Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin. Arthritis Rheum. 1981;24:1414-1418.
3. Cantini F, Niccoli L, Storri L, Nannini C, Olivieri I, Padula A, Boiardi L, Salvarani C. Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum. 2004;33:294-301.
4. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med. 1982;97:672-680.
5. Cid MC, Font C, Oristrell J, de la Sierra A, Coll-Vinent B, Lopez-Soto A, Vilaseca J, Urbano-Marquez A, Grau JM. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum. 1998;41:26-32.
6. Cid MC, Hernandez-Rodriguez J, Esteban MJ, Cebrian M, Gho YS, Font C, Urbano-Marquez A, Grau JM, Kleinman HK. Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant-cell arteritis. Circulation. 2002;106:1664-1671.
7. De Kleijn EM, Vandenbroucke JP, van der Meer JW. Fever of unknown origin (FUO). I. A prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore). 1997;76:392-400.
8. Desmet GD, Knockaert DC, Bobbaers HJ. Temporal arteritis: the silent presentation and delay in diagnosis. J Intern Med. 1990;227:237-240.
9. Gonzalez-Gay MA. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions. Semin Arthritis Rheum. 2004;33:289-293.
10. Gonzalez-Gay MA, Alonso MD, Aguero JJ, Bal M, Fernandez-Camblor B, Sanchez-Andrade A. Temporal arteritis in a northwestern area of Spain: Study of 57 biopsy proven patients. J Rheumatol. 1992;19:277-280.
11. Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WE. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum. 2003;33:38-48.
12. Gonzalez-Gay MA, Blanco R, Rodriguez-Valverde V, Martinez-Taboada VM, Delgado-Rodriguez M, Figueroa M, Uriarte E. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum. 1998;41:1497-1504.
13. Gonzalez-Gay MA, Blanco R, Sanchez-Andrade A, Vazquez-Caruncho M. Giant cell arteritis in Lugo, Spain: a more frequent disease with fewer classic features. J Rheumatol. 1997;24:2166-2170.
14. Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitis in adults in northwestern Spain, 1988-97. Clinical and epidemiologic aspects. Medicine (Baltimore). 1999;78:292-308.
15. Gonzalez-Gay MA, Garcia-Porrua C. Epidemiology of the vasculitides. Rheum Dis Clin North Am. 2001;27:729-749.
16. Gonzalez-Gay MA, Garcia-Porrua C, Amor-Dorado JC, Llorca J. Influence of age, sex, and place of residence on clinical expression of giant cell arteritis in northwest Spain. J Rheumatol. 2003;30:1548-1551.
17. Gonzalez-Gay MA, Garcia-Porrua C, Amor-Dorado JC, Llorca J. Giant cell arteritis without clinically evident vascular involvement in a defined population. Arthritis Rheum. 2004;51:274-277.
18. Gonzalez-Gay MA, Garcia-Porrua C, Amor-Dorado JC, Llorca J. Fever in biopsy-proven giant cell arteritis: Clinical implications in a defined population. Arthritis Rheum. 2004;51:652-655.
19. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Hajeer AH, Branas F, Dababneh A, Gonzalez-Louzao C, Rodriguez-Gil E, Rodriguez-Ledo P, Oilier WE. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore). 2000;79:283-292.
20. Gonzalez-Gay MA, Garcia-Porrua C, Pineiro A, Pego-Reigosa R, Llorca J, Hunder GG. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain. A population-based study. Medicine (Baltimore). 2004;83:335-341.
21. Gonzalez-Gay MA, Garcia-Porrua C, Rivas MJ, Rodriguez-Ledo P, Llorca J. Epidemiology of biopsy proven giant cell arteritis in north-western Spain: trend over an 18 year period. Ann Rheum Dis. 2001;60:367-371.
22. Gonzalez-Gay MA, Garcia-Porrua C, Rodriguez-Ledo P, Llorca J. Trends in the inflammatory response in biopsy-proven giant cell arteritis: comment on the article by Cid et al, and the letters by Nesher and Sonnenblick and Liozon et al. Arthritis Rheum. 2000;43:1427-1428.
23. Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. J Rheumatol. 1998;25:1750-1755.
24. Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M, Dababneh A, Hajeer A, Ollier WE. The spectrum of polymyalgia rheumatica in northwestern Spain: Incidence and analysis of variables associated with relapse in a ten year-study. J Rheumatol. 1999;26:1326-1332.
25. Gonzalez-Gay MA, Hajeer AH, Dababneh A, Garcia-Porrua C, Amoli MM, Llorca J, Ollier WER. Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica. Clin Exp Rheumatol. 2004;22(Suppl 36): S18-S20.
26. 25a. Gonzalez-Gay MA, Lopez-Diaz MJ, Barros S, Garcia-Porrua C, Sanchez-Andrade A, Paz-Carreira J, Martin J, Llorca J. Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. Medicine (Baltimore). 2005;84:277-290.
27. Gonzalez-Gay MA, Pineiro A, Gomez-Gigirey A, Garcia-Porrua C, Pego-Reigosa R, Dierssen-Sotos T, Llorca J. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore). 2004;83:342-347.
28. Healey LA. The spectrum of polymyalgia rheumatica. Clin Geriatr Med. 1988;4:323-331.
29. Healey LA. The relation of giant cell arteritis to polymyalgia rheumatica. Baillieres Clin Rheumatol. 1991;5:371-378.
30. Healey LA, Wilske KR. Presentation of occult giant cell arteritis. Arthritis Rheum. 1980;23:641-643.
31. Hellmann DB. Temporal arteritis: a cough, toothache, and tongue infarction. JAMA. 2002;287:2996-3000.
32. Hernandez-Rodriguez J, Segarra M, Vilardell C, Sanchez M, Garcia-Martinez A, Esteban MJ, Queralt C, Grau JM, Urbano-Marquez A, Palacin A, Colomer D, Cid MC. Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis. Rheumatology (Oxford). 2004;43:294-301.
33. Hunder GG. Giant cell arteritis and polymyalgia rheumatica. Med Clin North Am. 1997;81:195-219.
34. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW, Masi AT, McShane DJ, Mills JA, Wallace SL, Zvaifler NJ. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122-1128.
35. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978;88:162-167.
36. Levine SM, Hellmann DB. Giant cell arteritis. Curr Opin Rheumatol. 2002;14:3-10.
37. Lie JT, and the Members and Consultants of the American College of Rheumatology Subcommittee on classification of vasculitis. Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum. 1990;33:1074-1087.
38. Machado EB, Michel CJ, Ballard DJ, Hunder GG, Beard CM, Chu CP, O'Fallon WM. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum. 1988;31:745-749.
39. Papadakis MA, Schwartz MD. Temporal arteritis after normalization of erythrocyte sedimentation rate. Arch Intern Med. 1986;146:2283-2284.
40. Pego-Reigosa R, Garcia-Porrua C, Pineiro A, Dierssen T, Llorca J, Gonzalez-Gay MA. Predictors of cerebrovascular accidents in giant cell arteritis in a defined population. Clin Exp Rheumatol. 2004;22(Suppl 36):S13-S17.
41. Rynes RI, Mika P, Bartholomew LE. Development of giant cell (temporal) arteritis in a patient "adequately" treated for polymyalgia rheumatica. Ann Rheum Dis. 1977;36:88-90.
42. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347:261-271.
43. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med. 1995;123:192-194.
44. Weyand CM, Ma-Krupa W, Goronzy JJ. Immunopathways in giant cell arteritis and polymyalgia rheumatica. Autoimmun Rev. 2004;3:46-53.
45. Weyand CM, Tetzlaff N, Bjornsson J, Brack A, Younge B, Goronzy JJ. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum. 1997;40:19-26.